Literature DB >> 32689623

Association between post-stroke disability and 5-year hip-fracture risk: The Women's Health Initiative.

Carin A Northuis1, Carolyn J Crandall2, Karen L Margolis3, Susan J Diem4, Kristine E Ensrud5, Kamakshi Lakshminarayan6.   

Abstract

BACKGROUND: Hip fractures are a significant post-stroke complication. We examined predictors of hip fracture risk after stroke using data from the Women's Health Initiative (WHI). In particular, we examined the association between post-stroke disability levels and hip fracture risk.
METHODS: The WHI is a prospective study of 161,808 postmenopausal women aged 50-79 years. Trained physicians adjudicated stroke events and hip fractures. Our study included stroke survivors from the observational and clinical trial arms who had a Glasgow Outcome Scale of good recovery, moderately disabled, or severely disabled and survived more than 7 days post-stroke. Hip fracture-free status was compared across disability levels. Secondary analysis examined hip fracture risk while accounting for competing risk of death.
RESULTS: Average age at time of stroke was 74.6±7.2 years; 84.3% were white. There were 124 hip fractures among 4,640 stroke survivors over a mean follow-up time of 3.1±1.8 years. Mortality rate was 23.3%. Severe disability at discharge (Hazard Ratio (HR): 2.1 (95% Confidence Interval (CI): 1.4-3.2), but not moderate disability (HR: 1.1 (95%CI: 0.7-1.7), was significantly associated with an increased risk of hip fracture compared to good recovery status. This association was attenuated after accounting for mortality. White race, increasing age and higher Fracture Risk Assessment Tool (FRAX)-predicted hip fracture risk (without bone density information) were associated with an increased hip fracture risk. After accounting for mortality, higher FRAX risk and white race remained significant.
CONCLUSION: Severe disability after stroke and a higher FRAX risk score were associated with risk of subsequent hip fracture. After accounting for mortality, only the FRAX risk score remained significant. The FRAX risk score appears to identify stroke survivors at high risk of fractures. Our results suggest that stroke units can consider the incorporation of osteoporosis screening into care pathways.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glasgow Outcome Scale; Hip Fracture; Stroke; Women

Mesh:

Year:  2020        PMID: 32689623      PMCID: PMC7394038          DOI: 10.1016/j.jstrokecerebrovasdis.2020.104976

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  41 in total

1.  Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke.

Authors:  A Ramnemark; L Nyberg; R Lorentzon; U Englund; Y Gustafson
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

2.  Acute and long-term increase in fracture risk after hospitalization for stroke.

Authors:  J Kanis; A Oden; O Johnell
Journal:  Stroke       Date:  2001-03       Impact factor: 7.914

3.  Risk of fractures after stroke: Results from the Ontario Stroke Registry.

Authors:  Moira K Kapral; Jiming Fang; Shabbir M H Alibhai; Peter Cram; Angela M Cheung; Leanne K Casaubon; Marla Prager; Melissa Stamplecoski; Brennan Rashkovan; Peter C Austin
Journal:  Neurology       Date:  2016-11-23       Impact factor: 9.910

4.  Determinants of bone mineral density in immobilization: a study on hemiplegic patients.

Authors:  A del Puente; N Pappone; M G Mandes; D Mantova; R Scarpa; P Oriente
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 5.  Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  Carolee J Winstein; Joel Stein; Ross Arena; Barbara Bates; Leora R Cherney; Steven C Cramer; Frank Deruyter; Janice J Eng; Beth Fisher; Richard L Harvey; Catherine E Lang; Marilyn MacKay-Lyons; Kenneth J Ottenbacher; Sue Pugh; Mathew J Reeves; Lorie G Richards; William Stiers; Richard D Zorowitz
Journal:  Stroke       Date:  2016-05-04       Impact factor: 7.914

6.  Sleep duration and risk of ischemic stroke in postmenopausal women.

Authors:  Jiu-Chiuan Chen; Robert L Brunner; Hong Ren; Sylvia Wassertheil-Smoller; Joseph C Larson; Douglas W Levine; Matthew Allison; Michelle J Naughton; Marcia L Stefanick
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

7.  Bone mineral density alterations in upper and lower extremities 12 months after stroke measured by peripheral quantitative computed tomography and DXA.

Authors:  Olga Lazoura; Nikos Groumas; Eleftheria Antoniadou; Paraskevi J Papadaki; Alexandros Papadimitriou; Paschalis Thriskos; Ioannis Fezoulidis; Marianna Vlychou
Journal:  J Clin Densitom       Date:  2008-07-18       Impact factor: 2.617

8.  The influence of gender and age on disability following ischemic stroke: the Framingham study.

Authors:  Margaret Kelly-Hayes; Alexa Beiser; Carlos S Kase; Amy Scaramucci; Ralph B D'Agostino; Philip A Wolf
Journal:  J Stroke Cerebrovasc Dis       Date:  2003 May-Jun       Impact factor: 2.136

9.  Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.

Authors:  Arjun Seth; Yasmin Mossavar-Rahmani; Victor Kamensky; Brian Silver; Kamakshi Lakshminarayan; Ross Prentice; Linda Van Horn; Sylvia Wassertheil-Smoller
Journal:  Stroke       Date:  2014-09-04       Impact factor: 7.914

10.  Risk of fractures after stroke.

Authors:  Devin L Brown; Lewis B Morgenstern; Jennifer J Majersik; Michael Kleerekoper; Lynda D Lisabeth
Journal:  Cerebrovasc Dis       Date:  2007-12-06       Impact factor: 2.762

View more
  1 in total

1.  The Interaction Effect Between Previous Stroke and Hip Fracture on Postoperative Mortality: A Nationwide Cohort Study.

Authors:  Thomas J Hjelholt; Søren P Johnsen; Peter K Brynningsen; Alma B Pedersen
Journal:  Clin Epidemiol       Date:  2022-04-27       Impact factor: 5.814

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.